Skip to main content

Table 2 Frequency of anti-HCV ELISA reactivity and HCV infection in the 4 different studied subgroups.

From: Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology

Group n Anti-HCV +ve HCV infection*
Haemodialysis Patients (HP) 813 276 (33.9%) 274 (33.4%)
HP Controls 623 7 (1.1%) 5 (0.8%)
Health care Workers (HCW) 149 7 (4.7%) 4 (2.7%)
HCW Controls 149 0 0
  1. * anti-HCV positive by ELISA and immunoblot or PCR positive. +ve = positive